Thyroid Hormone Receptor, alpha (THRA) (C-Term) Peptide
-
- Target See all THRA products
- THRA (Thyroid Hormone Receptor, alpha (THRA))
- Protein Region
- C-Term
- Origin
- Rat
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- MSTDRSGLLC VDKIEKSQEA YLLAFEHYVN HRKHNIPHFW PKLLMKVTDL
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-Thra Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- THRA (Thyroid Hormone Receptor, alpha (THRA))
- Background
-
Thra binds the promoter of the Na+/H+ exchanger NHE1 and mediates thyroid hormone induced transcriptional activation.
Alias Symbols: ERBA1, Thra1
Protein Interaction Partner: PIK3R1,Pik3r1
Protein Size: 492 - Molecular Weight
- 55 kDa
- Gene ID
- 81812
- NCBI Accession
- NM_001017960, NP_001017960
- UniProt
- P63059
-